Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sellberg

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cytotherapy|November 26, 2016
Assessing the purity of regulatory T cells: A humble reminderErik Berglund, Felix Sellberg, David Berglund
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 1, 2016
Inflammatory cytokines in serum samples of healthy blood donorsFelix Sellberg, Martin Ronaghi, Folke Knutson, et al.
Frontiers in Immunology|December 2, 2020
Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin <i>In Vitro</i>Christian Binder, Felix Sellberg, Filip Cvetkovski, et al.
Frontiers in Oncology|January 28, 2021
Polyvinyl Alcohol Carbazate as a Polymer-Based Antitumoral AgentFelix Sellberg, Robin Fröbom, Christian Binder, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 3, 2023
Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitroFilip Cvetkovski, Ronia Razavi, Felix Sellberg, et al.
International Journal of Molecular Sciences|June 10, 2022
Serum Proteomics in Patients with Head and Neck Cancer: Peripheral Blood Immune Response to TreatmentThorsteinn Astradsson, Felix Sellberg, Ylva Tiblom Ehrsson, et al.
International Journal of Molecular Sciences|February 25, 2023
Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell CarcinomaKarl Sandström, Ylva Tiblom Ehrsson, Felix Sellberg, et al.
Frontiers in Immunology|March 1, 2021
Siplizumab Induces NK Cell Fratricide Through Antibody-Dependent Cell-Mediated CytotoxicityChristian Binder, Felix Sellberg, Filip Cvetkovski, et al.
Frontiers in Oncology|November 22, 2019
Systemic Inflammatory Reaction in Patients With Head and Neck Cancer-An Explorative StudyThorsteinn Astradsson, Felix Sellberg, David Berglund, et al.
Transfusion|February 10, 2017
Standardizing the freeze-thaw preparation of growth factors from platelet lysateGabriel Strandberg, Felix Sellberg, Pehr Sommar, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cytotherapy|November 26, 2016
Assessing the purity of regulatory T cells: A humble reminderErik Berglund, Felix Sellberg, David Berglund
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 1, 2016
Inflammatory cytokines in serum samples of healthy blood donorsFelix Sellberg, Martin Ronaghi, Folke Knutson, et al.
Frontiers in Immunology|December 2, 2020
Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin <i>In Vitro</i>Christian Binder, Felix Sellberg, Filip Cvetkovski, et al.
Frontiers in Oncology|January 28, 2021
Polyvinyl Alcohol Carbazate as a Polymer-Based Antitumoral AgentFelix Sellberg, Robin Fröbom, Christian Binder, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 3, 2023
Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitroFilip Cvetkovski, Ronia Razavi, Felix Sellberg, et al.
International Journal of Molecular Sciences|June 10, 2022
Serum Proteomics in Patients with Head and Neck Cancer: Peripheral Blood Immune Response to TreatmentThorsteinn Astradsson, Felix Sellberg, Ylva Tiblom Ehrsson, et al.
International Journal of Molecular Sciences|February 25, 2023
Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell CarcinomaKarl Sandström, Ylva Tiblom Ehrsson, Felix Sellberg, et al.
Frontiers in Immunology|March 1, 2021
Siplizumab Induces NK Cell Fratricide Through Antibody-Dependent Cell-Mediated CytotoxicityChristian Binder, Felix Sellberg, Filip Cvetkovski, et al.
Frontiers in Oncology|November 22, 2019
Systemic Inflammatory Reaction in Patients With Head and Neck Cancer-An Explorative StudyThorsteinn Astradsson, Felix Sellberg, David Berglund, et al.
Transfusion|February 10, 2017
Standardizing the freeze-thaw preparation of growth factors from platelet lysateGabriel Strandberg, Felix Sellberg, Pehr Sommar, et al.
Pageof 2